Glory Health Industry Limited (2329.HK) Stock Overview
Explore Glory Health Industry Limited’s financial performance, market position, analyst ratings, and future outlook.
Glory Health Industry Limited (2329.HK)
Key Financials
Key Financials
Market Cap
471.1M
P/E Ratio
-0.21
EPS (TTM)
$-0.48
ROE
-0.24%
2329.HK Stock Analysis & Investment Overview (HKSE)
Our AI-powered analysis of Glory Health Industry Limited (HKSE: 2329.HK) gives investors deep insight into how the stock performs on the HKSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Glory Health Industry Limited's HKSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of 2329.HK on the HKSE shows an RSI of 53.06, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.13 for the HKSE listing.
Key metrics behind Glory Health Industry Limited's HKSE-traded stock include a P/E ratio of -0.21 and a market capitalization of 471.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of 2329.HK on the HKSE.